Tag Archive for: Fresenius Medical Care

Kidney dialysis kit-makers look set to be the latest victim of the obesity drug boom. On Wednesday, shares in Germany-listed Fresenius Medical Care fell 20% after a medical trial showed a Novo Nordisk drug can reduce the risk of kidney failure.

In addition, Kabi has invested heavily in its fledgling biosimilars business, a maker of lower-cost versions of complex biotech drugs that have lost patent protection, and has started launching products in the United States.

Fresenius Medical Care shares hit their highest level in nearly seven months on Wednesday, welcoming news that FMC parent Fresenius would cede control over the struggling dialysis firm but keep its stake for now as part of a turnaround plan.

The world’s largest dialysis company is seeking out kidney disease patients long before they need the most acute form of care as it plans for growth of new drugs that attack the condition’s causes early on.

In a perplexing social paradox, diseases that disproportionately affect people of color are frequently also ones that receive less attention from the medical world. Compounding the problem, diseases that affect people across all races often have fewer people of color in clinical trials for new treatments. The reasons for the problem are widely speculated.